Development of a mouse monoclonal antibody for the purification of a yeast-derived recombinant hepatitis B surface antigen

Minerva Biotecnologica

Volumn 9, Issue 2, 1997, Pages 76-84

  De Cossío, Maria Elena Fernândez ^a   Valdés, Rodolfo ^a   Agraz, Alberto ^a   Pérez, Lilia ^a   González Griego, Marta ^a   García, Gerardo ^a   Valdivia, Irina ^b   Gavilondo, Jorge V ^a,c  

^a CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

^b Immunoassay Center Cuba   (Cuba)

^c Palo Alto Institute of Molecular Medicine   (United States)

Author keywords

Antibodies; Chromatography affinity; Hepatitis B surface antigens; Hepatitis B vaccines; Monoclonal

Indexed keywords

ENGERIX BTM; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; MONOCLONAL ANTIBODY; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN PURIFICATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; IMMUNOAFFINITY CHROMATOGRAPHY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION;

ANIMALIA;

EID: 0030795721     PISSN: 11204826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Stirk HJ, Thornton JM, Howard CR. A topological model for hepatitis B surface antigen. Intervirology 1992;33:148-58.
2. Howard CR, Burrell CJ. Structure and nature of hepatitis B antigen. Prog Med Virol. Basel, Karger 1976;22:36-103.
3. Neurath AR, Kent SBH. Antigenic structure of human hepatitis virus. In: Van Regenmortal MHV, Neurath AR, editors. Immunochemistry of viruses. Amsterdam: Elsevier 1985:36-103.
4. Peterson DL, Paul DA, Lam J, Tribby HE, Achord DT. Antigenic structure of hepatitis B surface antigen: identification of the -d-subtype determinant by chemical modification and use of monoclonal antibodies. J Immunol 1984;132(2):920-7.
5. Le Bouvier GH, Capper RH, Williams AE, Pelletier A, Katz AJ. Concurrently circulating hepatitis B surface antigen and heterotypic anti-HBs antibody. J Immunol 1976;117:2262-4.
6. Szmuness E, Stevens CE, Harley EJ et al. A Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980;303:833-41.
7. Jilg W, Lorbeer B, Schmidt H, Wilske B, Zoulek G, Deinhardt F. Clinical evaluation of a recombinant hepatitis B vaccine. Lancet 1984;i:1174-5.
8. Peterson DL. The structurre of hepatitis B surface antigen and its antigenic sites. Bioessays 1987;6:258-62.
9. Bitter GA. Hepatitis B vaccine produced in yeast. J Med Virol 1988;25:123-40.
10. André FE. Overview of 5 year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990;8(Suppl):S74-S78.
11. Penton E, Herrera L, Muzio V et al. Method for obtaining recombinant surface antigen of hepatitis B viais (Hep B) of higher immunogenic capacity and use there of in a vaccine preparation 1992;Eur Pat Apl 480-525.
12. Wands JR, Carlson RI, Schoemaker H, Isselbacher KJ, Zurawski VR. Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies. Proc Natl Acad Sci USA 1981;78(2): 1214-8.
13. Wands JR, Wong MA, Shorey J et al. Hepatitis B viral antigenic structure: Signature analysis by monoclonal radioimmunoassays. Proc Natl Acad Sci USA 1984;81:2237-41.
14. Kennedy RC, Ionescu-Matiu I, Adler-Storthz K et al. Characterization of antihepatitis B surface antigen monoclonal antibodies. Intervirology 1983;19:176-80.
15. Wampler DE, Buynak EB, Harder BJ et al. Hepatitis B vaccine purification by immunoaffinity chromatography. In: Lerner RA, Chanock RM, editors. Modern approaches to vaccines molecular and chemical basis of virus virulence and immunogenicity. New York Cold Spring Harbor Laboratory 1984:251-6.
16. Agraz A, Duarte CA, Costa L et al. Immunoaffinity purification of recombinant hepatitis B surface antigen from yeast using a monoclonal antibody. J Chromatogr 1994;A,672:25-33.
17. Fontirrochi G, Dueñas M, Fernández de Cossio ME et al. A mouse hybridoma cell line secreting IgG and IgM surface antigen. Biotecnol Aplic 1993;10(1):24-30.
18. Pentón E, Muzio V, González M. The Hepatitis B virus (HBV) infection and its prevention by a recombinant DNA viral surface antigen (rec. HBsAg) vaccines. Biotecnol Aplic 1994;11:1-11.
19. Duarte CA, Fernández de Cossio ME, Sierra G et al. Mouse monoclonal antibodies against human recombinant alpha 2 interferon. Their use in the purification and detection of the antigen. Biotecnol Aplic 1987;4:221-32.
20. Ouchterlony O. Antigen-antibody reactions in gels. Ark Kemi Mineral Geol 1949;26:1.
21. Danielson A, Ljunglof A, Lindblom H. One step puritication of monoclonal IgG antobodies from mouse ascites. J Immunol Methods 1988;115:79-88.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970;227:680-5.
23. Bayer EA, Wilchek M. The use of avidin-biotin complex as a tool in molecular biology. Methods Biochem Anal 1980;26:1-45.
24. Hougtnen RA, De Graw ST, Bray MK, Hoffman SR, Frizzell ND. Simultaneous multiple peptide synthesis: the rapid preparation of large numbers of discrete peptides for biological, immunological, and methodological studies. Biotechniques 1986;4: 522-8.
25. Fernández C, Castellanos L, Rodriguez P. Reverse staining of SDS-PA gels by imidazole-zinc salts: sensitive detection of unmodified proteins. Biotechniques 1992;12:564-73.
26. Kyhse-Andersen J. Electroblotting of multiple gels: A simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 1984;10:203-9.
27. Kohn J, Wilchek M. The use of cyanogen bromide and other novel cyanylating agents for the activation of polysaccharide resins. Appl Biochem Biotechnol 1984;9:285-304.
28. Anonimus. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirty-second Report Geneva World Health Organization, WHO Technical Report Series 1992;N.823,Annex 1.
29. Almeida JD. Electron microscopic observation and speculations of Australian antigen. Postgrad Med J 1971;47:848-57.
30. Woodman DD, Price CP. Clin Chem Act 1972;38:39.
31. Trevelyan WE, Harrison JS. Biochem J 1952;23:1824.
32. Lowry DH, Rosembrough NJ, Farr AL, Randal RJ. Protein measurements with the folinphenol reagent. J Biol Chem 1951;193:265-9.
33. Thanh LT, Man N, Mat B et al. Structural relationships between hepatitis B surface antigen in human plasma and dimers from recombinant vaccine: a monoclonal antibody study. Virus Res 1991;21:141-54.
34. Ashton-Rickardt PG, Murray K. Mutants of the hepatitis B virus surface antigen that define some antigenically essential residues in the immunodominant «a» region. J Med Virol 1989;29:196-203.
35. Sukeno N, Shirachi R, Yamaguchi J, Ishida N. Reduction and reoxidation of Australia antigen: loss and reconstitution of particle structure and antigenicity. J Virol 1972;9:182.
36. Vyas GN, Rao K, Ibrahim AB. Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science 1972;178:1300-1.
37. Dreesman GR, Hollinger FB, McCombs RM, Melnick JL. Alteration of hepatitis B antigen (HBAg) determinants by reduction and alkylation. J Gen Virol 1973;19:129.
38. Okamoto H, Imai M, Tsuda S et al. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 1987;61:3030-4.
39. Swenson PD, Peterson DL, Piesheng H. Antigenic analysis of HBsAg with monoclonal antibodies specific for S-protein and pre-S2 sequences. In: Zuckerman AJ, editor. Viral Hepatitis and Liver Disease. New York: Alan R Liss, Inc 1988:627-31.
40. Antoni BA, Peterson DL. Site directed mutagenesis of the hepatitis B surface antigen: creation of a free sulphydryl group and modification of the protein in the 22 nm particle structure. In: Zuckerman AJ, editor. Viral Hepatitis and Liver Disease. New York: Alan R Liss, Inc 1988:313-7.
41. Mangold CMT, Streeck RE. Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol 1993;67:4588-97.
42. Dunn MJ. Electrophoresis in the presence of additivies. In: Graham JM, Billington D, editors. Gel electrophoresis proteins. United Kingdom: Bios Scientific Publischers Limited 1993:41-9.